購読する
モデル製品
サービス
前臨床薬効評価
コミュ二ティー
HBB-bs & HBB-bt DKO Mouse
製品のお見積りを依頼する
当社のカタログから製品を選択してご注文ください。当社チームが詳細な情報をご連絡いたします。
HBB-bs & HBB-bt DKO Mouse
製品名
HBB-bs & HBB-bt DKO Mouse
製品ID
C001508
系統名
C57BL/6JCya-Hbb-bsem1Hbb-btem1/Cya
背景情報
C57BL/6JCya
状況
このマウス系統を論文で使用する場合は、「HBB-bs & HBB-bt DKO Mouse(カタログ番号C001508)はサイアジェンから購入しました。」と引用してください。
Disease Animal Models
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
お見積もりについてはこちらまでご連絡ください
Disease Animal Models
基本情報
検証 Data
関連リソース
基本情報
遺伝子別名
Hbbt1, Hbbt2, Beta-s, Beta-t
染色体
Chr 7, Chr 7
MGI ID
さらに
系統詳細
β-thalassemia is a genetic blood disorder caused by reduced or absent production of β-globin chains, the major protein component of hemoglobin. Hemoglobin is responsible for transporting oxygen throughout the body and comprises two α-globin chains and two β-globin chains [1]. Each chain contains a heme group at the center of the hemoglobin molecule, which binds an iron ion and gives hemoglobin its oxygen-carrying ability. In normal adult humans, the β-globin chains are encoded by the HBB gene. Adult hemoglobin (HbA), composed of two β-globin chains and two α-globin chains (encoded by the HBA1 or HBA2 genes), accounts for approximately 97% of total hemoglobin [2]. In β-thalassemia patients, HBB gene mutations cause reduced or absent β-globin chain production, leading to low hemoglobin levels and symptoms such as impaired erythropoiesis, hemolysis, and anemia. β-Thalassemia is caused by reduced (β+) or absent (β0) synthesis of the β-globin chains of hemoglobin [3]. Three clinical and hematological conditions of increasing severity are recognized: the β-thalassemia carrier state, thalassemia intermedia, and thalassemia major, severe transfusion-dependent anemia. The severity of disease expression is related mainly to the degree of α-globin chain excess, which precipitates in the red blood cell precursors, causing both mechanic and oxidative damage (ineffective erythropoiesis) [4]. Any mechanism that reduces the number of unbound α-globin chains in the red cells may ameliorate the detrimental effects of excess α-globin chains. Factors include the inheritance of mild/silent β-thalassemia mutations, the coinheritance of α-thalassemia alleles, and increased γ-globin chain production.
C57BL/6Cya mice have two similar adult β-globin protein-encoding genes, Hbb-bs and Hbb-bt. These two genes are located at adjacent positions on mouse chromosome 7 and contain three exons [5-6]. Hbb-bs & Hbb-bt DKO mice are a β-thalassemia disease model constructed by simultaneously knocking out the Hbb-bs gene and Hbb-bt gene in C57BL/6JCya mice using gene editing technology. This model is homozygous lethal, and heterozygous mice show typical features of severe thalassemia, such as abnormal hemoglobin content, red blood cell count, hematocrit, mean corpuscular hemoglobin concentration, red cell distribution width, platelet count, spleen size, and red cell morphology, and have reproductive ability.
参考文献
Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 May 21;5:11.
Hardison RC. Evolution of hemoglobin and its genes. Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a011627.
Thein SL. Molecular basis of β thalassemia and potential therapeutic targets. Blood Cells Mol Dis. 2018 May;70:54-65.
Origa R. β-Thalassemia. Genet Med. 2017 Jun;19(6):609-619.
Zhang F, Zhang B, Wang Y, Jiang R, Liu J, Wei Y, Gao X, Zhu Y, Wang X, Sun M, Kang J, Liu Y, You G, Wei D, Xin J, Bao J, Wang M, Gu Y, Wang Z, Ye J, Guo S, Huang H, Sun Q. An extra-erythrocyte role of haemoglobin body in chondrocyte hypoxia adaption. Nature. 2023 Oct;622(7984):834-841.
Trimborn T, Gribnau J, Grosveld F, Fraser P. Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci. Genes Dev. 1999 Jan 1;13(1):112-24.
系統作製戦略
Using gene editing technology, the Hbb-bs and Hbb-bt genes of C57BL/6Cya mice were simultaneously knocked out in one step.

Figure 1. Diagram of the gene editing strategy for the generation of HBB-bs & HBB-bt DKO mice.
適用分野
This model is a valuable tool for studying the mechanisms of β-thalassemia and screening potential therapeutic agents.
検証 Data
関連リソース
お問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
